title: Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12-month randomized controlled study.
abstract: BACKGROUND
  After a hip fracture, a catabolic state develops, with increased bone loss during the first year. The aim of this study was to evaluate the effects of postoperative treatment with calcium, vitamin D, and bisphosphonates (alone or together) with nutritional supplementation on total hip and total body bone mineral density (BMD).
  
  
  METHODS
  Seventy-nine patients (56 women), with a mean age of 79 years (range, 61-96 years) and with a recent hip fracture, who were ambulatory before fracture and without severe cognitive impairment, were included. Patients were randomized to treatment with bisphosphonates (risedronate 35 mg weekly) for 12 months (B; n=28), treatment with bisphosphonates along with nutritional supplementation (40 g protein, 600 kcal daily) for the first 6 months (BN; n=26), or to controls (C; n=25). All participants received calcium (1,000 mg) and vitamin D3 (800 IU) daily. Total hip and total body BMD were assessed with dual-energy X-ray absorptiometry at baseline, 6, and 12 months. Marker of bone resorption C-terminal telopeptide of collagen I and 25-hydroxy vitamin D were analyzed in serum.
  
  
  RESULTS
  Analysis of complete cases (70/79 at 6 months and 67/79 at 12 months) showed an increase in total hip BMD of 0.7% in the BN group, whereas the B and C groups lost 1.1% and 2.4% of BMD, respectively, between baseline and 6 months (P=0.071, between groups). There was no change in total body BMD between baseline and 12 months in the BN group, whereas the B group and C group both lost BMD, with C losing more than B (P=0.009). Intention-to-treat analysis was in concordance with the complete cases analyses.
  
  
  CONCLUSIONS
  Protein-and energy-rich supplementation in addition to calcium, vitamin D, and bisphosphonate therapy had additive effects on total body BMD and total hip BMD among elderly hip fracture patients.
authors.affiliation: Department of Geriatric Medicine, Karolinska University Hospital Stockholm, Sweden ; Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden.
authors.forename: Lena
authors.initials: L
authors.lastname: Flodin
authors.affiliation: Department of Endocrinology, Metabolism, and Diabetes, Karolinska University Hospital, Stockholm, Sweden;
authors.forename: Maria
authors.initials: M
authors.lastname: Sääf
authors.affiliation: Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden.
authors.forename: Tommy
authors.initials: T
authors.lastname: Cederholm
authors.affiliation: Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden ; Department of Orthopedics, Karolinska University Hospital, Stockholm, Sweden.
authors.forename: Amer N
authors.initials: AN
authors.lastname: Al-Ani
authors.affiliation: Department of Orthopedics, Karolinska University Hospital, Stockholm, Sweden ; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
authors.forename: Paul W
authors.initials: PW
authors.lastname: Ackermann
authors.affiliation: Department of Clinical Science, Division of Orthopedics, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.
authors.forename: Eva
authors.initials: E
authors.lastname: Samnegård
authors.affiliation: Department of Clinical Science, Division of Orthopedics, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.
authors.forename: Nils
authors.initials: N
authors.lastname: Dalen
authors.affiliation: Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden ; Department of Orthopedics, Karolinska University Hospital, Stockholm, Sweden.
authors.forename: Margareta
authors.initials: M
authors.lastname: Hedström
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D015519:Bone Density / Q000187:drug effects*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage; D016723:Bone Remodeling / Q000187:drug effects*; D002136:Calcium, Dietary / Q000008:administration & dosage*; D019587:Dietary Supplements; D004164:Diphosphonates / Q000008:administration & dosage*; D005260:Female; D006620:Hip Fractures / Q000378:metabolism / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control; D011184:Postoperative Period; D016896:Treatment Outcome; D014807:Vitamin D / Q000008:administration & dosage*; D014815:Vitamins / Q000008:administration & dosage
chemical_list: D015415:Biomarkers; D050071:Bone Density Conservation Agents; D002136:Calcium, Dietary; D004164:Diphosphonates; D014815:Vitamins; D014807:Vitamin D
keywords: bisphosphonates; bone mineral density; hip fracture; nutritional supplementation